About Alexander Smikodub Jr. M.D. & UCTC

Smikodub Unique Cell Treatment Clinic

Alexander Smikodub Jr. M.D.

UNIQUE CELL TREATMENT CLINIC is a medical center the history of which goes back to 1994. For over 15 years the founder of our clinic Professor Alexander Smikodub Sr. was the head of the clinic developing and introducing unique methods of stem cell treatment. Now his son Alexander Smikodub Jr. continues this unique treatment commenced by his father. During the years of work our clinic has performed about 6 500 transplantations of fetal stem cells. Our treatment has helped prolong life, improve its quality and in many cases completely cure thousands of patients from all over the world (the USA, Italy, Germany, China, the Russian Federation, Poland, etc.), who had lost any hope for recovery.

UNIQUE CELL TREATMENT CLINIC professionals provide fetal stem cell treatment (in vivo), develop comprehensive treatment for severe acquired and hereditary diseases caused by or resulting in cell count reduction. Moreover, a wide range of conditions such as aging, infertility, menopause, chronic fatigue syndrome and functional disorders of internal organs are treated at our clinic.

The clinic has a license for all the stem cell treatment methods developed by Alexander Smikodub Sr., Alexander Smikodub Jr. and its other specialists. All the methods are protected by the patents of Ukraine, Russia, the USA and other countries. At the present time, a number of patents on fetal stem cell application for treatment of various diseases and conditions are considering in the patent offices of many countries.

In the BBC documentary our clinic was called the “Last Hope Clinic” because we treat and follow-up the most severe clinical cases from all over the world.

During many years of work UNIQUE CELL TREATMENT CLINIC (UCTC) has won international recognition in the branch of research and treatment of patients by unique methods with application of fetal stem cells (in vivo). Our achievements were awarded a number of certificates of international medical conferences and congresses. But the most valuable award for UNIQUE CELL TREATMENT CLINIC is successful treatment and recovery of our patients, their words of gratitude.

History of the clinic

UNIQUE CELL TREATMENT CLINIC has a glorious history connected with the invention of medicinal preparations based on fetal stem cells and their clinical application. Here we were the pioneers and remain the leaders.

The scientific potential of our center is the huge knowledge and experience of our specialists and staff, it is a great deal of information published all over the world, it is a big number of reports and lectures at various congresses and conferences, it is scientific degrees and dissertations defended by our employees. By February, 2009 the specialists of our center under the supervision of Professor Alexander Smikodub Sr. and later of his son Alexander Smikodub Jr. up to June, 2011, provided medical services to patients from all over the world under the EmCell trademark.

In June, 2011 the company EmCell Embryonic Tissue Center Ltd. was divided between its owners according to their shares. Dr. Alexander Smikodub Jr. restructured his clinical base into a separate clinic with a well-developed infrastructure and a modern laboratory. The clinic provides its services under the UNIQUE CELL TREATMENT CLINIC trademark.

However, despite all reorganization processes, the center still has a long scientific history, a wealth of clinical experience and thousands of grateful patients we helped.

Our scientific history

1987

 

treatment of patients with cytostatic myelodepression and aplastic anemia (filing of patent application).

1991

 

clinical trials and invention of acquired immune deficiency syndrome (AIDS) and HIV-infection treatment method; filing of patent application in the USA (priority since 1993).

1992

 

successful application of fetal stem cells (in vivo) in clinical trials for treatment of type 1 and 2 diabetes mellitus, filing of patent application

1993...1994

 

foundation of the Cell Therapy Clinic of the NationalMedicalUniversity (17 Solomenskaya Str., Kiev, Ukraine). Clinical trials of cell transplants for treatment of different diseases and conditions. First Ukrainian patents granted. The beginning of development of multiple sclerosis treatment methods.

1995

 

application of fetal stem cells (in vivo) for treatment of amyotrophic lateral sclerosis. First efforts to apply different types of cell suspensions for treatment of muscular dystrophies, in particular Duchenne Muscular Dystrophy

1998...2001

 

Greek, USA, Russian Federation and Ukrainian patents granted.

1999

 

Ministry of Healthcare of Ukraine approval of methodological recommendations on application of fetal stem cells in oncology, developed by the clinic.

2000

 

Ministry of Healthcare of Ukraine approval of methodological recommendations on application of fetal stem cells in diabetes treatment, developed by the clinic.

2001

 

Ministry of Healthcare of Ukraine approval of methodological recommendations on application of fetal stem cells in hematology, developed by the clinic.

2002

 

“Most Innovative Work” Award granted by the Scientific Committee of the Annual Meeting of the Society of Medical Innovations and Technology (SMIT) held in Oslo, Norway. The first Dutch patent granted. Ministry of Healthcare of Ukraine approval of methodological recommendations on application of fetal stem cells in endocrinology, developed by the clinic.

2003

 

the second Dutch patent granted.

2004

 

Ukrainian and Russian Federation patents granted. Development and patenting of methods of intestine diseases treatment (Crohn’s disease, non-specific ulcerative colitis, etc.). Working out of ethical norms on the work with human fetal cells approved by the Ministry of Healthcare of Ukraine.

2005...2007

 

extension of active clinical and scientific activities, participation in the numerous conferences and congresses, direct participation in the work of international societies and associations, such as Cellular Therapy Society, Cell Transplant Society, Multinational Association of Supportive Care in Cancer, Society for Minimally Invasive Therapy, EASD.

2008

 

development of methods of fetal cell suspensions application in surgical practice, in particular for treatment of erosive-ulcerative lesions of stomach and duodenum complicated by bleeding. Elaboration of patient surveillance that was declared the best at the 1-st Central European Congress on Surgery (Prague, Czech Republic).

2009

 

Ukrainian patents granted

2010

 

Beginning of different cell suspensions application for treatment of thermal injuries of various complexity and localization.

 

Biotechnology of stem cell isolation and storage


UNIQUE CELL TREATMENT CLINIC uses modern methods of fetal stem cell isolation, production and storage. We ourselves produce medicinal preparations based on fetal cell suspensions, test them and use for treatment and scientific researches. Creation of medicinal preparations based on fetal cell suspensions and treatment of patients by the same organization is a perfect combination that lets us be confident of high quality of the cell transplant and allows to reach the most positive results.

Biotechnological stages of work with medicinal preparations based on fetal cell suspension:

  1. Timely and safe collection of the best quality fetal material in specialized departments in compliance with the Ethical Committee requirements.
  2. Preparing of medicinal preparations based on fetal cell suspension and putting them into sterile containers.
  3. Safety and viability testing of medicinal preparations based on fetal cell suspension before cryopreservation.
  4. Programmed cryopreservation of cell transplants.
  5. Safety and viability testing of defrosted medicinal preparations based on fetal cell suspension before their use.
  6. Long-term storage of medicinal preparations based on fetal cell suspension in cryobanks.

 

Cell suspension bank

UNIQUE CELL TREATMENT CLINIC owns a modern cell suspension bank with high-tech equipment. It includes modern Dewar flasks and cryogenic banks (tanks) of large volumes with tens of thousands of fetal cell suspensions samples.


Patents

The clinic has a license for all the methods of stem cell treatment developed by Alexander Smikodub Sr., Alexander Smikodub Jr., and its other specialists as part of EmCellCenter. All the methods are protected by the patents of Ukraine, Russia, the USA and other countries. At present, a number of patent applications on fetal stem cell for different diseases and conditions treatment are pending in the patent offices of many countries. Patenting has always been a priority direction in the activity of UNIQUE CELL TREATMENT CLINIC. Alexander Smikodub Sr. was the first person in the world to describe post-transplantation period after fetal stem cell treatment for such diseases as AIDS, HIV-infection, type 1 and 2 diabetes mellitus, aplastic anemia, psoriasis, rheumatoid arthritis, degenerative diseases of nervous system, inflammatory and cancer bowel diseases, etc.

In 1993, International Patent Application Examination Board in the Hague awarded Professor Smikodub’s patents level "A", that is absolutely innovative works.

In his patents Professor Smikodub described the possibility of treatment for a large number of diseases and conditions caused by or resulting in cell count reduction. We are most proud of Doctor Smikodub’s patents granted in the United States of America and the Netherlands.

Professor Smikodub was the first in the world to offer medicinal preparations based on fetal stem cells and mentioned this in his US, Dutch, Russian and Ukrainian patents. We believe that in the nearest future fetal cell suspensions in the form of medicinal preparations will be available in specialized drugstores for treatment in inpatient or outpatient departments.

This is a brand-new ideology of practical medicine when medical professional will issue prescription for purchasing cell composite consisting of HLA-free stem cells. It is them that will help to cope with illness- or age-related cell deficiency.

UNIQUE CELL TREATMENT CLINIC welcomes cooperation for the development of this idea.

Scientific activities

Our scientific work belongs to the modern branch of science called cell therapy. We gave our definition of this branch of science. Cell therapy is the science about stem cells and their clinical application.

It was in the 1990’s that we realized that this was the science of the method. It is enough to see the main indication for its use ? different cell count reduction resulted from the disease – and you can be sure that in this case cell therapy will be effective.

Almost all severe acquired and hereditary diseases cause destruction of actively functioning cells. Stem cells capable of proliferation (multiplication), differentiation (specialization) and morphogenesis (tissue formation) are effective for tissue and organ function and cell count restoration.

Stem cells of fetal origin are the most effective in achieving the above-mentioned effects as they have the highest proliferative potential. Our clinical observations have shown how unique the method is.

Since 1991, 7 MMS theses were written by postgraduate students and teachers of the Therapy Chair of the National Medical University of Ukraine for whom Professor Alexander Smikodub Sr. was a scientific advisor.

The range of our scientific interests has been wide: clinical researches and working out of treatment methods for type 1 and 2 diabetes mellitus, AIDS, HIV-infection, leukosis, aplastic anemia, primary and secondary thrombocytopenia, cytostatic myelodepression, oncological diseases, degenerative diseases of central nervous system, multiple sclerosis, amyotrophic lateral sclerosis, muscular dystrophies, thermal injuries of various localization; such conditions as menopause, infertility, aging, as well as functional disturbances of internal organs, chronic fatigue syndrome, application of fetal stem cell suspensions in surgical practice, etc.

Our specialists regularly attend international and national scientific conferences where they present reports and give lectures. 
 
UNIQUE CELL TREATMENT CLINIC professionals are the authors of more than 300 scientific publications in national as well as international medical journals and congress proceedings.

Our clinic owns the trademark “UCTC” registered in the USA, Russia and Ukraine.

We own websites uctclinic.com, cell-treatment.ru.


A lot of positive articles have been published about Alexander Smikodub Sr.’s method of treatment, and 4 documentaries have been made, including a film by BBC.


We are available at:

Address  Kiev, Ukraine, 03110, P.O.Box 8
e-mail  infocenter@cell-treatment.com
Telephone +38 067 2090691